Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan-Kettering investigators.

Memorial Sloan-Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.

While a diagnosis of cervical cancer once required a hysterectomy, a procedure called a radical trachelectomy eliminated Stephanie Luedke’s cancer and preserved her ability to bear a child.

Research has shown that children who have experienced a sunburn at an early age are at almost double the risk for developing melanoma in adulthood. Now, a new study led by Memorial Sloan-Kettering epidemiologist Stephen Dusza finds that most children do not regularly use sunscreen.

When actor Michael Quinlan was diagnosed with prostate cancer, he came to Memorial Sloan-Kettering to learn about treatment options from our multidisciplinary team of experts. After undergoing robot-assisted laparoscopic surgery, he remains cancer-free.

Researchers at Memorial Sloan-Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.

Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.